ASSEMBLY BIOSCIENCES INC

HQ - South San Francisco

Summary

Assembly Biosciences is a biopharmaceutical company focused on developing novel, oral therapies to treat chronic infectious diseases, particularly hepatitis B virus (HBV) and herpesviruses, with the goal of improving patient outcomes and potentially achieving cures.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 34 M

Avg. Deal Size£ 34 M

Market Context

Senior Management

Jason Okazaki
CEO